New EACPT Virtual Focus Meeting 2021

Abstract presenters will be given the choice to either present abstracts virtually this year for the new EACPT Virtual Focus Meeting. 28-29 June 2021 OR save them for the postponed EACPT Congress in Athens, 26-28 June 2022 (see more details on the front page).

Please note that only abstracts that have NOT been previously published will be accepted. This means that abstracts can only be presented during the EACPT Congress next year in Athens if not published elsewhere in the meantime. A link with the two options will be sent to abstract submitters before 12 March.

The submitting author will receive a confirmation of acceptance for oral presentation, poster presentation, or a notice of rejection, by email by 15 April 2021.

Abstract submission guidelines

Deadline for submission through the Submission Website: Thursday February 18, 2021 at 23.59hours (CET).

You should only submit an abstract if you intend to attend the congress either on-line or physical presence. If your abstract is accepted for oral or poster presentation you must register for the congress. Posters will be presented in electronic form, and if physical presence is possible, there may be also an area for poster mounting and discussion with physical presence. The organizers reserve the right to remove from publication any abstract whose author does not register within two weeks of receipt of the acceptance letter.

Acceptance notification

All abstracts received by the indicated deadline will be evaluated by a panel of experts. The submitting author will receive a confirmation of acceptance for oral presentation, poster presentation, or a notice of rejection, by email by 15 April 2021.

Abstract structure and content

• Language: Abstracts should be written in English.
• Abstract title: The title (including spaces) should not exceed 200 characters and should be written in sentence case. Please do not type a full stop (.) at the end of the title.
• Topics: When asked to select an abstract topic from the list provided, select at least one topic matching the content of your abstract best.
• Keywords: You may enter a maximum of 6 keywords, describing the content of your abstract for scheduling and indexing purposes. Avoid general terms.
• Abstract text: The abstract should not exceed 2.500 characters including spaces and punctuation. The abstract title is included in the overall character count. The abstract must be structured in the following five specified subtitles: Introduction, Objectives, Methods, Results and Conclusion. A table can be inserted for inclusion in the abstract.
• Registration of authors: Names, titles, institutional affiliations, cities, countries and email addresses of all contributing authors should be provided. The presenting author (not necessarily the first author) should be identified.
• Only abstracts not previously published will be accepted.

Abstract topics

Advanced therapies Immunotherapies
Antimicrobials Intensive care treatment
Bioinformatics and systems pharmacology Misuse of medicines/substances
Cancer treatment Nephropharmacology
Cardiovascular treatment Patient empowerment
Chronic diseases Pediatric treatment
Computerized decision support Pharmacogenetics/omics
COVID-19 therapies and vaccines Pharmacokinetics/pharmacodynamics
Drug regulation Pharmacovigilance
Drug utilization Professional development
Drug-drug interactions Psychopharmacology
Education Rare diseases
Geriatric treatment Therapeutic drug monitoring
Health economy